Raúl Gómez Riera

Title: Raúl Gómez Riera: Innovator in Pharmaceutical Composition

Introduction

Raúl Gómez Riera is a notable inventor based in Ciudad de la Habana, Cuba. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions aimed at combating tumor growth. His innovative work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Raúl Gómez Riera holds a patent for a pharmaceutical composition containing polypeptide fragments of serralysins. This invention is designed to inhibit the growth of tumoral cells from various histological origins and activated endothelial cells. The composition includes polypeptide fragments corresponding to the C-terminal fragment of serralysins, which can be combined with prodigiosins to enhance the antitumoral effect. The prodigiosins are present in concentrations ranging from 0.1 to 100 nM. The anti-proliferative action of this composition is mediated through apoptotic mechanisms, and its in vivo administration demonstrates antitumoral, antiangiogenic, and protective effects against malignant tumors.

Career Highlights

Raúl Gómez Riera is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.

Collaborations

Some of his notable coworkers include Maria Del Carmen Abrahantes Pérez and Jesús Reyes González. Their collaborative efforts contribute to the ongoing research and development in the field of biotechnology.

Conclusion

Raúl Gómez Riera's contributions to pharmaceutical compositions represent a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the field of biotechnology.